Literature DB >> 702337

Structure-activity relationships of natural and synthetic cannabinoids in suppression of humoral and cell-mediated immunity.

S H Smith, L S Harris, I M Uwaydah, A E Munson.   

Abstract

Delta-9-Tetrahydrocannabinol (delta-9-THC) a psychoactive constituent of marihuana, has been shown in previous studies to suppress humoral and cell-mediated immunity. The objective of this study was to determine whether structural modification of delta-9-THC would result in a more potent immunosuppressant agent devoid of central nervous system activity. The ED50 for reduction of the humoral immune response to sheep erythrocytes as measured by spleen plaque forming cells/10(6) spleen cells was 70 mg/kg for delta-9-THC. Delta-8-THC, 1-methyl delta-8-THC and abnormal delta-8-THC were more potent with ED50 values of 14, 13 and 8 mg/kg, respectively. Cell-mediated immunity was evaluated by a delayed-type hypersensitivity response to sheep erythrocytes. At doses of 100 mg/kg s.c. for 4 days, the cannabinoids suppressed the delayed-type hypersensitivity response from 35 to 64%. These data show that the cannabinoids can cause immunosuppression which is not related to central nervous system activity since 1-methyl delta-8-THC and abnormal delta-8-THC have minimal central nervous system activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 702337

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

Review 1.  Effects of Cannabinoids on T-cell Function and Resistance to Infection.

Authors:  Toby K Eisenstein; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-16       Impact factor: 4.147

2.  Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus.

Authors:  P S Morahan; P C Klykken; S H Smith; L S Harris; A E Munson
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

Review 3.  CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies.

Authors:  A Arévalo-Martín; D García-Ovejero; O Gómez; A Rubio-Araiz; B Navarro-Galve; C Guaza; E Molina-Holgado; F Molina-Holgado
Journal:  Br J Pharmacol       Date:  2007-09-24       Impact factor: 8.739

Review 4.  AIDS, drugs of abuse and the immune system: a complex immunotoxicological network.

Authors:  R Pillai; B S Nair; R R Watson
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

5.  Evaluation of immune response to anti-COVID-19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels.

Authors:  Cohen Idan; Campisi-Pinto Salvatore; Rozenberg Orit; Abaev Ariel; Khoury Marah; Agbaria Dana; Eitam Harel; Colodner Raul; Khoury Mona; Shalabna Hassan; Samih Yousef; Mahamid Camel; Abu-Amna Mahmoud; Bar-Sela Gil
Journal:  Cancer Commun (Lond)       Date:  2022-08-22

6.  Psychoimmunology and infection.

Authors:  Thomas W Klein
Journal:  Clin Microbiol Newsl       Date:  2002-11-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.